<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Neon Therapeutics, Inc.

    Neon Therapeutics, Inc.

    Neon Therapeutics is a clinical-stage immuno-oncology company leading in the field...

    Neon Therapeutics is a clinical-stage immuno-on...

    Filing Type:    PU
    So-Young International Inc.

    So-Young International Inc.

    So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”) is ...

    So-Young International Inc. (NASDAQ: SY) (“So...

    Filing Type:    PU
    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc.

    HOOKIPA Pharma Inc. is a clinical stage biopharmaceutical company developing a new...

    HOOKIPA Pharma Inc. is a clinical stage biophar...

    Filing Type:    PU
    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focu...

    Anthera Pharmaceuticals, Inc., a development st...

    Amount Raised:    $65,500,000
    Fundraising Status:    VT
    Filing Type:    PU
    Lonza Group AG

    Lonza Group AG

    Lonza is an integrated solutions provider that creates value along the Healthcare ...

    Lonza is an integrated solutions provider that ...

    Filing Type:    PU
    Oxford Immunotec Global PLC

    Oxford Immunotec Global PLC

    We are a global, high-growth diagnostics company committed to improving patient ca...

    We are a global, high-growth diagnostics compan...

    Filing Type:    PU
    Meridian Bioscience Inc.

    Meridian Bioscience Inc.

    Meridian is a fully integrated life science company that develops, manufactures, m...

    Meridian is a fully integrated life science com...

    Filing Type:    PU
    Atrion Corporation

    Atrion Corporation

    As a leading manufacturer of medical devices and components, Atrion makes a wide r...

    As a leading manufacturer of medical devices an...

    Filing Type:    PU
    Bellerophon Therapeutics, Inc.

    Bellerophon Therapeutics, Inc.

    At Bellerophon Therapeutics, we aim to transform the lives of people suffering fro...

    At Bellerophon Therapeutics, we aim to transfor...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.